Anavex Life Sciences (AVXL) Competitors $9.12 +0.30 (+3.40%) Closing price 04:00 PM EasternExtended Trading$9.11 -0.01 (-0.11%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AVXL vs. SWTX, PTGX, CPRX, MRUS, ALVO, APLS, SRRK, CRNX, IMVT, and ACADShould you be buying Anavex Life Sciences stock or one of its competitors? The main competitors of Anavex Life Sciences include SpringWorks Therapeutics (SWTX), Protagonist Therapeutics (PTGX), Catalyst Pharmaceuticals (CPRX), Merus (MRUS), Alvotech (ALVO), Apellis Pharmaceuticals (APLS), Scholar Rock (SRRK), Crinetics Pharmaceuticals (CRNX), Immunovant (IMVT), and ACADIA Pharmaceuticals (ACAD). These companies are all part of the "pharmaceutical products" industry. Anavex Life Sciences vs. SpringWorks Therapeutics Protagonist Therapeutics Catalyst Pharmaceuticals Merus Alvotech Apellis Pharmaceuticals Scholar Rock Crinetics Pharmaceuticals Immunovant ACADIA Pharmaceuticals Anavex Life Sciences (NASDAQ:AVXL) and SpringWorks Therapeutics (NASDAQ:SWTX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk. Does the media prefer AVXL or SWTX? In the previous week, Anavex Life Sciences and Anavex Life Sciences both had 6 articles in the media. SpringWorks Therapeutics' average media sentiment score of 1.14 beat Anavex Life Sciences' score of 0.75 indicating that SpringWorks Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anavex Life Sciences 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SpringWorks Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer AVXL or SWTX? Anavex Life Sciences presently has a consensus target price of $44.00, suggesting a potential upside of 388.35%. SpringWorks Therapeutics has a consensus target price of $73.20, suggesting a potential upside of 96.46%. Given Anavex Life Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Anavex Life Sciences is more favorable than SpringWorks Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33SpringWorks Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AVXL or SWTX more profitable? Anavex Life Sciences has a net margin of 0.00% compared to SpringWorks Therapeutics' net margin of -134.73%. Anavex Life Sciences' return on equity of -37.50% beat SpringWorks Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Anavex Life SciencesN/A -37.50% -34.08% SpringWorks Therapeutics -134.73%-46.74%-41.12% Do insiders and institutionals have more ownership in AVXL or SWTX? 31.5% of Anavex Life Sciences shares are owned by institutional investors. 11.0% of Anavex Life Sciences shares are owned by company insiders. Comparatively, 7.6% of SpringWorks Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer AVXL or SWTX? Anavex Life Sciences received 336 more outperform votes than SpringWorks Therapeutics when rated by MarketBeat users. Likewise, 74.92% of users gave Anavex Life Sciences an outperform vote while only 71.62% of users gave SpringWorks Therapeutics an outperform vote. CompanyUnderperformOutperformAnavex Life SciencesOutperform Votes44274.92% Underperform Votes14825.08% SpringWorks TherapeuticsOutperform Votes10671.62% Underperform Votes4228.38% Which has better earnings & valuation, AVXL or SWTX? Anavex Life Sciences has higher earnings, but lower revenue than SpringWorks Therapeutics. Anavex Life Sciences is trading at a lower price-to-earnings ratio than SpringWorks Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnavex Life SciencesN/AN/A-$43M-$0.55-16.38SpringWorks Therapeutics$191.59M14.57-$325.10M-$3.48-10.71 Which has more volatility & risk, AVXL or SWTX? Anavex Life Sciences has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, SpringWorks Therapeutics has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. SummaryAnavex Life Sciences beats SpringWorks Therapeutics on 13 of the 17 factors compared between the two stocks. Remove Ads Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVXL vs. The Competition Export to ExcelMetricAnavex Life SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$766.43M$2.89B$5.32B$7.56BDividend YieldN/A1.91%5.11%4.33%P/E Ratio-16.3830.8821.7717.81Price / SalesN/A435.82378.2693.59Price / CashN/A168.6838.1534.64Price / Book6.353.476.443.99Net Income-$43M-$72.06M$3.20B$247.23M7 Day Performance18.55%8.57%6.42%7.24%1 Month Performance-4.45%-17.48%-8.66%-6.26%1 Year Performance113.00%-29.58%10.27%-0.18% Anavex Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVXLAnavex Life Sciences3.3651 of 5 stars$9.12+3.4%$44.00+382.5%+105.4%$775.78MN/A-16.5840Gap DownSWTXSpringWorks Therapeutics2.0543 of 5 stars$36.96-5.4%$73.20+98.0%-12.4%$2.77B$191.59M-10.62230Positive NewsPTGXProtagonist Therapeutics3.8077 of 5 stars$43.30-2.6%$62.56+44.5%+66.5%$2.66B$434.43M16.28120Positive NewsCPRXCatalyst Pharmaceuticals4.6047 of 5 stars$21.83-5.4%$32.29+47.9%+49.8%$2.65B$491.73M18.5080Positive NewsGap DownMRUSMerus2.8304 of 5 stars$37.27-2.2%$85.31+128.9%+1.4%$2.57B$36.13M-9.4337Positive NewsGap DownALVOAlvotech1.7084 of 5 stars$8.33-2.1%$18.00+116.2%-30.3%$2.51B$489.68M-4.501,026Analyst RevisionGap DownAPLSApellis Pharmaceuticals4.1441 of 5 stars$19.75-1.1%$45.59+130.9%-62.7%$2.48B$781.37M-9.73770Gap DownSRRKScholar Rock3.8819 of 5 stars$26.01-3.3%$42.67+64.0%+115.1%$2.46B$33.19M-11.07140Positive NewsCRNXCrinetics Pharmaceuticals3.5876 of 5 stars$26.38-1.9%$73.00+176.8%-33.2%$2.45B$1.04M-7.07210Positive NewsGap DownIMVTImmunovant2.3714 of 5 stars$14.36-1.5%$41.00+185.5%-47.4%$2.44BN/A-5.48120Short Interest ↑Gap DownACADACADIA Pharmaceuticals4.0179 of 5 stars$14.62-4.9%$23.93+63.7%-13.3%$2.44B$957.80M18.74510Analyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies SWTX Alternatives PTGX Alternatives CPRX Alternatives MRUS Alternatives ALVO Alternatives APLS Alternatives SRRK Alternatives CRNX Alternatives IMVT Alternatives ACAD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVXL) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVXL Stock Free AVXL Stock Alerts